Last reviewed · How we verify

NCT03656445

Tranexamic Acid in Total Knee Replacement

Completed NA Last updated 5 September 2018
What this trial tests

NA trial testing Tranexamic Acid in Osteo Arthritis Knee in 180 participants. Completed in 31 March 2017.

Timeline
1 October 2015
Primary endpoint
31 March 2017
31 March 2017

Quick facts

Lead sponsorDemocritus University of Thrace
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment180
Start date1 October 2015
Primary completion31 March 2017
Estimated completion31 March 2017

Drugs / interventions tested

Conditions studied

Sponsor

Democritus University of Thrace

Who can join

Eligibility, any sex, with Osteo Arthritis Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multiple intravenous Tranexamic Acid doses can reduce postoperative blood loss and improve the functional outcome in total knee arthroplasty without tourniquet: a randomized controlled study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tranexamic Acid

Trials testing the same drug.

Other recruiting trials for Osteo Arthritis Knee

Currently open trials in the same condition.

Other Democritus University of Thrace trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03656445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing